CDKN2A and cancer: Overexpression of p16 (p16+) in HPV-HR infection has been demonstrated in a high percentage of cervical and HNC cancers [5-7] and it has been suggested that p16INK4a expression may serve as a surrogate biomarker of oncogenic HPV infection in predicting HPV-related tumors [8,9].